Bristol-Myers Squibb | BMY - Capital Y Las Reservas

Precio De Mercado
57.59
Cambio Diario
-0.67 -1.15%
Mensual
-3.58%
Anual
14.72%
Q2 Expectativa
57.45




Capital Y Las Reservas Cambio Fecha
AbbVie USD -3.27B 628M 2025-12
Abbott USD 52.06B 69M 2026-03
ALKERMES USD 1.82B 85.86M 2025-12
Amgen USD 8.66B 961M 2025-12
AstraZeneca USD 47.33B 1.33B 2026-03
Biogen USD 18.65B 394.9M 2026-03
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Coherus Biosciences USD 61.01M 26.76M 2025-12
Drreddys Laboratories INR 4.14B 107.72M 2025-12
Eli Lilly USD 26.54B 2.74B 2025-12
Gilead Sciences USD 22.62B 1.16B 2025-12
GlaxoSmithKline GBP 16.38B 229M 2025-12
J&J USD 81.19B 358M 2026-03
Medtronic USD 48.99B 128M 2025-12
Merck USD 51.85B 2.79B 2025-09
Novartis USD 46.13B 1.38B 2025-12
Novo Nordisk DKK 194.05B 24.15B 2025-12
Perrigo USD 2.94B 1.51B 2025-12
Pfizer USD 92.8B 4.11B 2025-09
Phibro Animal Health USD 332.36M 20.68M 2025-12
Prestige Brands USD 1.83B 4.48M 2025-12
Regeneron Pharmaceuticals USD 31.42B 166.7M 2026-03
Roche Holding CHF 33.8B 758M 2025-12
Sanofi EUR 72.81B 1.1B 2026-03
Sanofi EUR 71.71B 14.25B 2025-12
United Therapeutics USD 7.1B 506M 2025-12
Zoetis USD 3.33B 2.07B 2025-12